Protocol Summaries: testosterone
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| TDC106222 | Phase 1 | An open label study to evaluate the impact of novel fixed-dose testosterone/dutasteride combinations on the relative bioavailability of the individual dutasteride and testosterone components | Completed |